Where it comes from
- Made in
- Liver and most tissues before birth; the liver mainly after
- Sent out by
- Steady; not under growth hormone in adults
- Acts on
- Fetal tissues
- Muscle
- Tumours that make it
What it does
- Drives fetal and placental growth 1
- Supports muscle repair and regeneration
- Circulates in adults at three times the level of IGF-1, with no settled job
In medicine
Beyond the body’s own use
- Not used as a medicine: there is no IGF-2 product, and the clinical problem it causes is too much of it rather than too little
- Blocking it is the direction of interest, in the cancers that make it, and that work is at the stage of antibodies and receptor inhibitors rather than trials 2
- In rodents, injected IGF-2 strengthened recall and the effect lasted weeks, which made it a memory candidate 3. It has not been tested in people, and the imprinting that controls the gene makes any attempt to raise it in a person a long way off
Sources
- Brioude et al., Diagnosis and management of Beckwith-Wiedemann syndrome: international consensus statement, Nature Reviews Endocrinology 2018
- Crowley et al., IGF-2 mediated hypoglycaemia: a case report and review of the literature, BMC Endocrine Disorders 2022
- Chen et al., A critical role for IGF-II in memory consolidation and enhancement, Nature 2011
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.